Delivery Order SPE2DE24DA010-SPE2D625F5F5L

Award Date 4/29/25
Potential Completion Date 5/2/25
Potential Value $26K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract, valued at $25,364.85, was awarded by the Defense Logistics Agency (DLA) and is a fixed-price delivery order contract with economic price adjustment. The contract has a completion date of February 5, 2025 and does not include a set-aside designation, indicating full and open competition....
This is a federal contract award to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, by the Defense Logistics Agency (DLA) and Department of Veterans Affairs (VA). The contract has an award value of $25,715.85 and is a firm fixed-price delivery order with economic price adjustment. The contract covers the delivery of a variety of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $44,742.80 fixed-price delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and surgical implants. The ultimate completion date for this contract is October 25, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $25,875.85, was made by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract is a delivery order for the provision of cardiovascular medical devices and related services, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract does not have a set-aside...
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a firm fixed-price delivery order with economic price adjustment, with an ultimate completion date of June 18, 2024. The award provides for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants....
This federal contract award, valued at $1,262.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a multinational pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract is a fixed-price delivery order with economic price adjustment, with a period of performance ending on March 27, 2025. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a key supplier of advanced...
This federal contract award is for $21,425.00 and was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a Delivery Order under an Indefinite Delivery Vehicle (IDV) and has a fixed price with economic price adjustment pricing type. The contract is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $2,800.00 fixed-price with economic price adjustment delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of June 17, 2024. This award is part of a larger...
This federal contract award, valued at $8,000.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large medical device manufacturer, through its Abbott Vascular Inc. division. The contract is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, cardiac monitors, and surgical implants. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F5F5L
    Delivery Order

This is a federal contract award to Abbott Laboratories Inc., a global healthcare company, by the Defense Logistics Agency (DLA). The $25,715.85 fixed-price delivery order is for the provision of cardiovascular medical devices and related services, including items such as stents, pacemakers, heart valves, and surgical implants. The contract has an ultimate completion date of May 2, 2025.

Abbott Laboratories Inc. is the prime contractor and has established itself as a critical supplier of advanced cardiovascular medical technologies to federal healthcare systems, particularly the Department of Veterans Affairs (VA) and the DLA. The company holds several significant Indefinite Delivery Contracts (IDCs) and Indefinite Delivery Vehicles (IDVs) with these agencies, showcasing its strategic importance in federal healthcare procurement. This contract award is not set aside and was awarded through full and open competition.

Generated 7/29/25, 9:59 AM